Leyla Hernandez Donoso

Home Our Speakers Speaker Details
Novo Nordisk
Leyla Hernandez Donoso

Senior Director of Real-World Evidence at Novo Nordisk

  Uetikon, Zurich, Switzerland

About me

Leyla is an epidemiologist with over 24 years of expertise in the pharmaceutical industry. Her career spans leadership roles at GSK, Takeda and Novartis in vaccines and drug development across Asia, Latin America, the USA, and Europe. With her deep understanding of the complexities of global healthcare landscapes, she had played a vital role in leveraging real-world data to fuel innovations and inform decision making . In her current role , she leads regional evidence generation efforts across multiple therapeutic areas; harnessing digital technologies and AI driven solutions to facilitate the patient access to new medicines and enhance its value.

Schedule

My Session

Use of AI to accelerate research in RWE, the case of SLR and predictive modelling

Leyla Hernandez Donoso

Senior Director of Real-World Evidence at Novo Nordisk


AI and ML in Pharma
Real-World Data (RWD) and Evidence (RWE)
Building the Future of Pharma Through Digital Collaboration and Innovation
  • Why collaboration between pharma, healthcare, and technology sectors is crucial for future progress
  • How pharmaceutical companies can adapt to evolving patient expectations in a digital-first world
  • How digital platforms and tools can enhance pharma-patient engagement and education
  • How companies are innovating through tech-enabled partnerships
  • Strategies to improve data flow, transparency, and communication across all stakeholders

Collaborative and Partnering Strategies
Digital Transformation
Drug Discovery and Development

Konrad Dobschuetz

Founder Director at Leap Advisory & Intelligence

Stijn Janssen

Design Lead Data Science at Novo Nordisk

Leyla Hernandez Donoso

Senior Director of Real-World Evidence at Novo Nordisk

Sravan Kumar Eduru

Angel Investor & AI Start up Advisor